2021
DOI: 10.3177/jnsv.67.145
|View full text |Cite
|
Sign up to set email alerts
|

Nicotinic Acid against Acetaminophen-Induced Hepatotoxicity via Sirt1/Nrf2 Antioxidative Pathway in Mice

Abstract: Acetaminophen (N-acetyl-p-aminophenol, APAP) overdose causes hepatotoxicity, even liver failure, and oxidative stress plays pivotal role in its pathogenesis. Nicotinic acid (NA) is one form of vitamin B3, which has been used to treat a series of diseases in clinic for decades. To date, several studies have evidenced that NA has anti-oxidative property. Therefore, NA may have the hepatoprotective potential against APAP-induced toxicity. Here, our aim was to investigate the beneficial effect of NA against hepato… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
3
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 12 publications
(6 citation statements)
references
References 33 publications
(38 reference statements)
1
3
0
Order By: Relevance
“…The APAP group showed a significant decrease in SIRT-1 expression level compared to the control group. This finding was in accordance with previously reported results ( Wang et al, 2020 ; Hu et al, 2021 ). On the other hand, PA administration significantly increased SIRT-1 expression levels in APAP-induced hepatotoxicity.…”
Section: Discussionsupporting
confidence: 94%
“…The APAP group showed a significant decrease in SIRT-1 expression level compared to the control group. This finding was in accordance with previously reported results ( Wang et al, 2020 ; Hu et al, 2021 ). On the other hand, PA administration significantly increased SIRT-1 expression levels in APAP-induced hepatotoxicity.…”
Section: Discussionsupporting
confidence: 94%
“…Taken together, these strategies establish bona fide NRF2 activation and a potential direct mechanism conferring protection. Current work suggesting that slight increases in protein/gene levels of NRF2 or an increased ratio of NRF2/KEAP1 does not provide sufficient evidence to state that NRF2 activation is responsible for the observed protection 199 .…”
Section: General Recommendations For Investigating Therapeutic Efficacy and Mechanisms Of Actionmentioning
confidence: 89%
“…The discovery that ferulic acid is a Sirt1 inducer may offer important insight into its effects on Nrf2 and NF-kappaB activities. Sirt1 promotes antioxidant phase 2 induction by deacetylating and enhancing the transcriptional activity of Nrf213–15; this effect likely contributes to the phase 2-inducing activity of ferulic acid, although activation of Erk1/2 is also thought to contribute in this regard 16–18. Ferulic acid-mediated induction of Sirt1 would also be expected to combat inflammation by reversing the acetylation of p65 on Lys310 required for optimal transactivation activity of the NF-kappaB complex 15 19.…”
Section: Upregulation Of Sirt1 By Ferulic Acidmentioning
confidence: 99%